Effectiveness of Bedaquiline Use beyond Six Months in Patients with Multidrug-Resistant Tuberculosis.

Saved in:
Bibliographic Details
Title: Effectiveness of Bedaquiline Use beyond Six Months in Patients with Multidrug-Resistant Tuberculosis.
Authors: Trevisi L; Department of Global Health and Social Medicine, Harvard Medical School, Boston, Massachusetts., Hernán MA; CAUSALab, Departments of Epidemiology, Harvard T.H. Chan School of Public Health, Harvard University, Boston, Massachusetts., Mitnick CD; Department of Global Health and Social Medicine, Harvard Medical School, Boston, Massachusetts.; Division of Global Health Equity, Brigham and Women's Hospital, Boston, Massachusetts.; Partners in Health, Boston, Massachusetts., Khan U; Interactive Research and Development Global, Singapore, Singapore., Seung KJ; Department of Global Health and Social Medicine, Harvard Medical School, Boston, Massachusetts.; Division of Global Health Equity, Brigham and Women's Hospital, Boston, Massachusetts.; Partners in Health, Boston, Massachusetts., Rich ML; Department of Global Health and Social Medicine, Harvard Medical School, Boston, Massachusetts.; Division of Global Health Equity, Brigham and Women's Hospital, Boston, Massachusetts.; Partners in Health, Boston, Massachusetts., Bastard M; Field Epidemiology Department, Epicentre, Paris, France., Huerga H; Field Epidemiology Department, Epicentre, Paris, France., Melikyan N; Field Epidemiology Department, Epicentre, Paris, France., Atwood SA; Division of Global Health Equity, Brigham and Women's Hospital, Boston, Massachusetts., Avaliani Z; National Center for Tuberculosis and Lung Diseases, Tbilisi, Georgia., Llanos F; Unidad de Tuberculosis, Hospital Nacional Dos de Mayo, Lima, Peru.; Instituto de Investigaciones en Ciencias Biomedicas, Universidad Ricardo Palma, Lima, Peru., Manzur-Ul-Alam M; Interactive Research and Development, Dhaka, Bangladesh., Zarli K; Médecins sans Frontières, Yangon, Myanmar., Binegdie AB; Department of Internal Medicine, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia., Adnan S; Indus Hospital and Health Network, Karachi, Pakistan., Melikyan A; Médecins sans Frontières, Yerevan, Armenia., Gelin A; Zanmi Lasante, Port-au-Prince, Haiti., Isani AK; National Core Research Group, Stop TB Partnership, Islamabad, Pakistan., Vetushko D; Republican Scientific and Practical Centre of Pulmonology and Tuberculosis, Minsk, Belarus., Daugarina Z; Astana City Center of Phthisiopulmonology, Astana, Kazakhstan., Nkundanyirazo P; Partners in Health, Maseru, Lesotho., Putri FA; Interactive Research and Development Global, Singapore, Singapore., Vilbrun C; GHESKIO, Port-au-Prince, Haiti., Khan M; Interactive Research and Development, Durban, South Africa., Hewison C; Medical Department, Médecins sans Frontières, Paris, France; and., Khan PY; Department of Clinical Research, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom., Franke MF; Department of Global Health and Social Medicine, Harvard Medical School, Boston, Massachusetts.
Source: American journal of respiratory and critical care medicine [Am J Respir Crit Care Med] 2023 Jun 01; Vol. 207 (11), pp. 1525-1532.
Publication Type: Clinical Trial; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Thoracic Society Country of Publication: England NLM ID: 9421642 Publication Model: Print Cited Medium: Internet ISSN: 1535-4970 (Electronic) Linking ISSN: 1073449X NLM ISO Abbreviation: Am J Respir Crit Care Med Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1535-4970
DOI:10.1164/rccm.202211-2125OC